Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | HPGD | P15428 | 4/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.35 |
| ▸ | PNPO | Q9NVS9 | 1/20 | 0.35 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.35 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | ACP1 | P24666 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4577607 | 0.79 | HPGD (0.51) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL4577063 | 0.79 | KDM4E (0.51) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL4576376 | 0.77 | KDM4E (0.50) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL4576782 | 0.75 | KDM4E (0.47) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL4577612 | 0.74 | KDM4E (0.63) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL13988518 | 0.74 | KDM4E (0.50) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL4576779 | 0.73 | KDM4E (0.56) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL4577021 | 0.72 | KDM4E (0.44) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL4577011 | 0.71 | KDM4E (0.67) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL5420563 | 0.70 | KDM4E (0.45) | KDM4EALDH1A1HPGDHSD17B10LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080311099-A1 | Pyridoxal-5-Phosphate and Related Compounds in Combination With Therapeutic Cardiovascular Compounds for Treating Angina | MEDICURE INTERNATIONAL INC. | 2008-12-18 | — | — | US | disclosed |
| US-7442689-B2 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (BB) | 2008-10-28 | — | — | US | disclosed |
| EP-1531157-B1 | Cardioprotective phosphonates | MEDICURE INT INC (BB) | 2008-03-19 | — | — | EP | disclosed |
| US-7105673-B2 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (BB) | 2006-09-12 | — | — | US | disclosed |
| EP-1531157-A1 | Cardioprotective phosphonates | Medicure International Inc. (BB) | 2005-05-18 | — | — | EP | disclosed |
| US-6867215-B2 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (BB) | 2005-03-15 | — | — | US | disclosed |
| US-6861439-B2 | Treatment of cerebrovascular disease | MEDICURE INTERNATIONAL, INC. (BB) | 2005-03-01 | — | — | US | disclosed |
| US-20040171588-A1 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (CA) | 2004-09-02 | — | — | US | disclosed |
| US-6780997-B2 | SUCH AS DIBENZYL(A,3-O-ISOPROPYLIDIENE-3-HYDROXY-4-HYDROXYMETHYL-2-METHYL-5-PYRIDYL) HYDROXYMETHYLPHOSPHONATE WHICH FUNCTIONS LIKE PYRIDOXAL-5'-PHOSPHATE IN VIVO; DRUG SCREENING; ANTIDIABETIC AGENTS | MEDICURE INTERNATIONAL INC. (BB) | 2004-08-24 | — | — | US | disclosed |
| US-20040121988-A1 | Treatment of cerebrovascular disease | MEDICURE INTERNATIONAL INC. (BB) | 2004-06-24 | — | — | US | disclosed |
| US-20030120074-A1 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (BB) | 2003-06-26 | — | — | US | disclosed |
| US-20030114677-A1 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (BB) | 2003-06-19 | — | — | US | disclosed |
| US-20030114424-A1 | Treatment of cerebrovascular disease | MEDICURE INTERNATIONAL INC. (BB) | 2003-06-19 | — | — | US | disclosed |
| US-20030114678-A1 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (BB) | 2003-06-19 | — | — | US | disclosed |
| EP-1278526-A2 | TREATMENT OF CEREBROVASCULAR DISEASE | Medicure International Inc. (BB) | 2003-01-29 | — | — | EP | disclosed |
| EP-1268498-A1 | CARDIOPROTECTIVE PHOSPHONATES AND MALONATES | Medicure International Inc. (BB) | 2003-01-02 | — | — | EP | disclosed |
| US-20020010158-A1 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (CA) | 2002-01-24 | — | — | US | disclosed |
| US-20010056081-A1 | Treatment of cerebrovascular disease | MEDICURE INTERNATIONAL INC. (CA) | 2001-12-27 | — | — | US | disclosed |
| WO-2001072309-A2 | TREATMENT OF CEREBROVASCULAR DISEASE | MEDICURE INTERNATIONAL INC. (US) | 2001-10-04 | — | — | WO | disclosed |
| WO-2001064692-A1 | CARDIOPROTECTIVE PHOSPHONATES AND MALONATES | MEDICURE INTERNATIONAL INC. (BB) | 2001-09-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030114677-A1 | Cardioprotective phosphonates and malonates | PDXK, PHOSPHO1, PNPO | KDM4E 519/4885ALDH1A1 2080/4885HPGD 403/4885 |
| US-20080311099-A1 | Pyridoxal-5-Phosphate and Related Compounds in Combination With Therapeutic Cardiovascular Compounds for Treating Angina | ALOX5, PNPO, KCNMB1 | KDM4E 1392/4885ALDH1A1 1179/4885HPGD 581/4885 |
| US-20020010158-A1 | Cardioprotective phosphonates and malonates | PDXK, PHOSPHO1, PNPO | KDM4E 519/4885ALDH1A1 2080/4885HPGD 403/4885 |
| US-20040121988-A1 | Treatment of cerebrovascular disease | PNPO, PLPBP, PDXK | KDM4E 1621/4885ALDH1A1 1627/4885HPGD 242/4885 |
| US-20030120074-A1 | Cardioprotective phosphonates and malonates | PDXK, PHOSPHO1, PNPO | KDM4E 519/4885ALDH1A1 2080/4885HPGD 403/4885 |
| US-20010056081-A1 | Treatment of cerebrovascular disease | PNPO, PLPBP, VNN1 | KDM4E 1422/4885ALDH1A1 1352/4885HPGD 156/4885 |
| US-20040171588-A1 | Cardioprotective phosphonates and malonates | PRDX5, FABP3, PRDX6 | KDM4E 2221/4885ALDH1A1 1489/4885HPGD 420/4885 |
| US-20030114678-A1 | Cardioprotective phosphonates and malonates | PDXK, PHOSPHO1, PNPO | KDM4E 519/4885ALDH1A1 2080/4885HPGD 403/4885 |
| US-20030114424-A1 | Treatment of cerebrovascular disease | PNPO, PLPBP, VNN1 | KDM4E 1422/4885ALDH1A1 1352/4885HPGD 156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.